Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients
Phase 1 clinical trials for sarcomas: the cutting edge
Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients
Phase II Study of Triplet Chemotherapy Using Tegafur-Uracil, Vinorelbine, Gemcitabine for Advanced Non-small Cell Lung Cancer
Phase I/II study of amrubicin in combination with S-1 as second-line chemotherapy for non-small-cell lung cancer without EGFR mutation
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer
Phase I Clinical Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258), an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors, in Patients with Advanced Melanoma
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows lowtoxicity and robust immunogenicity
Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
Phase I Trial of Sunitinib Malate plus Interferon-alpha for Patients with Metastatic Renal Cell Carcinoma
Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336
Phase diagram of D-2 adsorbed on graphene and graphite
Phase space portraits of an unresolved gravitational Maxwell demon
Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer
Phase I Trial of Gemcitabine Combined with Capecitabine and Erlotinib in Advanced Pancreatic Cancer: A Clinical and Pharmacological Study
Phase II Study of Gefitinib as a First-line Therapy in Elderly Patients with Pulmonary Adenocarcinoma: West Japan Thoracic Oncology Group Study 0402
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles
Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy
Phase-space structures - II. Hierarchical Structure Finder
Phase II Study of Erlotinib for Acquired Resistance to Gefitinib in Patients with Advanced Non-small Cell Lung Cancer
Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors
Phase II Trial of Pemetrexed Plus Gemcitabine in Patients With Locally Advanced and Metastatic Nonclear Cell Renal Cell Carcinoma
Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
Phase II study of S-1 monotherapy in platinum-refractory, advanced non-small cell lung cancer
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors
Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma
Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies
Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
Phase II clinical trials in oncology: are we hitting the target?
Phase 1 Study of Combination Treatment with PTK 787/ZK 222584 and Cetuximab for Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics Analysis
Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G(1) Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2
Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420
Phase 1 Study of AMG 386, a Selective Angiopoietin 1/2-Neutralizing Peptibody, in Combination with Chemotherapy in Adults with Advanced Solid Tumors
Phase II Trial of Bevacizumab and Everolimus in Patients With Advanced Renal Cell Carcinoma
Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer
Phase transfer of hydrophilic, cyclodextrin-modified gold nanoparticles to chloroform solutions
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the national cancer institute of Canada clinical trials group
Phase 2 study of ABT-510 in patients with previously untreated advanced renal cell carcinoma
Phase I and pharmacokinetic study of vatalanib plus capecitabine in patients with advanced cancer
Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma
Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors
Phase II trial of pegylated interferion-alpha 2b in patients with advanced renal cell carcinoma
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma
Phase 2 Study of High-Dose Proton Therapy With Concurrent Chemotherapy for Unresectable Stage III Nonsmall Cell Lung Cancer
Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer
Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status
Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma
Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations
Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer
Phase diagram and dynamics in Er1-xYxMnO3
Phase Diagram of a Geometrically Frustrated Triangular-Lattice Antiferromagnet in a Magnetic Field
Phase structure of the anisotropic antiferromagnetic Heisenberg model on a layered triangular lattice: Spiral state and deconfined spin liquid
Phase diagram of electron-doped dichalcogenides
Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy
Phase structure of monolayer graphene from effective U(1) gauge theory on honeycomb lattice
Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer
Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors
Phase Ib trial of bryostatin 1 in patients with refractory malignancies
Phase 4 research: what happens when the rubber meets the road?
Phase diagram of bosons in two-color superlattices from experimental parameters
Phase Transitions in Metal Clusters and Cluster Catalysts